Pelthos Therapeutics revenue was $16.80M for the trailing 12 months ending Dec 31, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2025) ending on Dec 31, 2025 was $9.4M, up 26.8% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, PTHS annual revenue was $16.8M, with Infinity% growth year-over-year.
PTHS past revenue growth
How has PTHS's revenue growth performed historically?
On Invalid Date, Pelthos Therapeutics (NYSEMKT: PTHS) reported Q4 2025 revenue of $9.39 million up Infinity% year over year. In the same quarter last year, Pelthos Therapeutics's revenue was $0.00.
What was Pelthos Therapeutics's revenue in 2025?
Pelthos Therapeutics's annual revenue for the twelve months ending Dec 31, 2025 was $16.80 million, a Infinity% increase year over year.
How much does Pelthos Therapeutics make in a day?
Based on Pelthos Therapeutics annual revenue for the past five years, PTHS makes an average of $9,202.74 per day.
What was Pelthos Therapeutics's annual revenue growth in the past year?
As of Q2 2026, Pelthos Therapeutics's revenue has grown null year over year. Pelthos Therapeutics's revenue in the past year totaled $16.80 million.
How much does Pelthos Therapeutics make in a year?
Pelthos Therapeutics's revenue by year for the past five years is:
Pelthos Therapeutics's revenue for the twelve months ending Dec 31, 2025 was $16.80 million, a Infinity% increase year over year.
Pelthos Therapeutics's annual revenue for Dec 31, 2024 was $0.00, a N/A decrease from 2023.
Pelthos Therapeutics's annual revenue for 2023 was $0.00, a N/A decrease from 2022.
Pelthos Therapeutics's annual revenue for 2022 was $0.00, a N/A decrease from 2021.
Pelthos Therapeutics's annual revenue for 2021 was $0.00, a 100% decrease from 2020.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.